NUVL Nuvalent
- 72.640
- +0.960+1.34%
Nuvalent News
Nuvalent Gains Breakthrough Therapy Status for Non-small Cell Lung Cancer Candidate
Nuvalent's NVL-655 Receives FDA Breakthrough Therapy Designation
Nuvalent's NVL-655 Receives FDA Breakthrough Therapy Designation
Nuvalent(NUVL.US) Director Sells US$2.47 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on May 13, 2024 at an average price of $65.84 for a total value of $2.47 million.Source: Announcement What is statement of
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Bluebird Bio (BLUE) and Nuvalent (NUVL)
Nuvalent (NUVL) Gets a Buy From Stifel Nicolaus
Nuvalent's Promising Clinical Progress and Financial Stability Support Strong Buy Rating
Nuvalent Q1 Net Loss Widens
Nuvalent (NUVL) reported a Q1 net loss Thursday of $0.69 per diluted share, widening from a loss of $0.44 a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.67 per share. The clinic
Nuvalent | 10-Q: Quarterly report
Nuvalent(NUVL.US) Director Sells US$2.61 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on May 6, 2024 at an average price of $69.48 for a total value of $2.61 million.Source: Announcement What is statement of
Nuvalent Insider Sold Shares Worth $2,605,525, According to a Recent SEC Filing
Matthew Shair, Director, on May 06, 2024, sold 37,500 shares in Nuvalent (NUVL) for $2,605,525. Following the Form 4 filing with the SEC, Shair has control over a total of 1,698,720 shares of the comp
Nuvalent(NUVL.US) Officer Sells US$216.2K in Common Stock
$Nuvalent(NUVL.US)$ Officer Miller Deborah Ann sold 3,000 shares of common stock on May 2, 2024 at an average price of $72.07 for a total value of $216.2K.Source: Announcement What is statement of cha
Nuvalent(NUVL.US) Director Sells US$2.67 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 39,500 shares of common stock on Apr 29, 2024 at an average price of $67.51 for a total value of $2.67 million.Source: Announcement What is statement of
Nuvalent Insider Sold Shares Worth $2,666,555, According to a Recent SEC Filing
Matthew Shair, Director, on April 29, 2024, sold 39,500 shares in Nuvalent (NUVL) for $2,666,555. Following the Form 4 filing with the SEC, Shair has control over a total of 1,736,220 shares of the co
Nuvalent(NUVL.US) Director Sells US$2.39 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on Apr 22, 2024 at an average price of $63.65 for a total value of $2.39 million.Source: Announcement What is statement of
We're Not Very Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring reve
Jefferies Starts Nuvalent at Buy, Cites Lung Cancer Drug Candidates
Nuvalent(NUVL.US) Director Sells US$327.61K in Common Stock
$Nuvalent(NUVL.US)$ Director Conley Emily sold 5,000 shares of common stock on Apr 15, 2024 at an average price of $65.52 for a total value of $327.61K.Source: Announcement What is statement of change
Nuvalent(NUVL.US) Director Sells US$2.46 Million in Common Stock
$Nuvalent(NUVL.US)$ Director Shair Matthew sold 37,500 shares of common stock on Apr 15, 2024 at an average price of $65.56 for a total value of $2.46 million.Source: Announcement What is statement of
Nuvalent Insider Sold Shares Worth $2,458,335, According to a Recent SEC Filing
Matthew Shair, Director, on April 15, 2024, sold 37,500 shares in Nuvalent (NUVL) for $2,458,335. Following the Form 4 filing with the SEC, Shair has control over a total of 1,813,220 shares of the co
Nuvalent Initiated at Buy by Jefferies
Nuvalent Initiated at Buy by Jefferies
Analysis
Price Target
No Data
